Cargando…
Genetic variations in VEGF and VEGFR2 and glioblastoma outcome
Vascular endothelial growth factor (VEGF) and its receptors (VEGFR) are central components in the development and progression of glioblastoma. To investigate if genetic variation in VEGF and VEGFR2 is associated with glioblastoma prognosis, we examined blood samples from 154 glioblastoma cases colle...
Autores principales: | Sjöström, S., Wibom, C., Andersson, U., Brännström, T., Broholm, H., Johansen, C., Collatz-Laier, H., Liu, Y., Bondy, M., Henriksson, R., Melin, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161189/ https://www.ncbi.nlm.nih.gov/pubmed/21191630 http://dx.doi.org/10.1007/s11060-010-0504-2 |
Ejemplares similares
-
Genetic variations in EGF and EGFR and glioblastoma outcome
por: Sjöström, Sara, et al.
Publicado: (2010) -
Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice
por: van Genugten, J. A. B., et al.
Publicado: (2009) -
Role of monoamine-oxidase-A-gene variation in the development of glioblastoma in males: a case control study
por: Sjöberg, Rickard L., et al.
Publicado: (2019) -
Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings
por: Hilverda, Karen, et al.
Publicado: (2009) -
Identification of diagnostic serum protein profiles of glioblastoma patients
por: Elstner, Anja, et al.
Publicado: (2010)